跳轉至內容
Merck
全部照片(1)

Key Documents

211-GS

Sigma-Aldrich

Endothelial Cell Growth Supplement (15ml)

同義詞:

Primary Cell Culture Media Supplement

登入查看組織和合約定價


About This Item

分類程式碼代碼:
12352207
NACRES:
NA.71

形狀

liquid

品質等級

儲存期限

1 yr

製造商/商標名

Cell Applications, Inc

運輸包裝

dry ice

儲存溫度

−20°C

一般說明

Added to Basal Medium to create Growth Medium
Human endothelial cell growth supplement is added to the basal medium to create growth medium. The complete growth medium (equivalent to Cat# 211-500) is optimized and best-suited for angiogenesis and other physiological studies.

應用

Endothelial Cell Growth Supplement (15ml) has been used as a supplement for culturing:
  • human type II alveolar cells
  • human umbilical vein endothelial cells (HUVEC)
  • human pulmonary artery endothelial cells (HPAECs)

品質

Each lot was tested for the ability to support plating, spreading and proliferation

準備報告

contained in protocol

儲存類別代碼

10 - Combustible liquids

水污染物質分類(WGK)

WGK 3


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Michelle V Mouritzen et al.
Journal of peptide science : an official publication of the European Peptide Society, 24(7), e3093-e3093 (2018-06-26)
Neurotensin, substance P, and insulin have been demonstrated to improve wound healing in vivo. However, the mechanism behind their effect is still not fully understood. This study investigates the effects leading to enhanced scratch closure by these peptides in vitro.
Koustav Ganguly et al.
Scientific reports, 10(1), 20460-20460 (2020-11-26)
Limited toxicity data on electronic cigarette (ECIG) impede evidence-based policy recommendations. We compared two popular mixed fruit flavored ECIG-liquids with and without nicotine aerosolized at 40 W (E-smoke) with respect to particle number concentrations, chemical composition, and response on physiologically relevant
Hong Xue et al.
International journal of chronic obstructive pulmonary disease, 16, 1329-1345 (2021-05-20)
Etanercept (ETN), a tumor necrosis factor-α (TNF-α) inhibitor, has been applied in the treatment of many diseases. However, whether it has effects on chronic obstructive pulmonary disease (COPD) and its interaction with tumor necrosis factor receptor 1 (TNFR1) remained unknown.

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務